Chen Yaru, Li Mengxu, Liu Xuanwei, Duan Qiyang, Xiao Lin, Wang Luxin, Huang Congcong, Song Hao, Cao Yingxiu
State Key Laboratory of Synthetic Biology, Tianjin University, Tianjin, China.
College of Life and Health Sciences, Northeastern University, Shenyang, China.
Microb Biotechnol. 2025 Apr;18(4):e70151. doi: 10.1111/1751-7915.70151.
The ability to regulate gene expression in multiple directions is crucial to maximise the production of microbial cell factories. However, the lack of a regulatory tool that can simultaneously activate and repress multiple genes restricts the manipulation diversity of Yarrowia lipolytica, which is an industrial workhorse for bioproduction. To address this issue, we developed a CRISPR scaffold RNAs (scRNAs)-mediated transcriptional activation and repression (CRISPR-STAR) platform. Firstly, we evaluated different methods for bidirectional regulation using CRISPR on both endogenous and synthetic promoters in Y. lipolytica, and chose the utilisation of orthogonal scRNAs to recruit activation and inhibition domains. Secondly, CRISPR-STAR was optimised by the introduction of alternative dCas proteins, scRNA structures and activators. 2.6-fold and 54.9-fold activation were achieved for synthetic and endogenous promoters, respectively, when the VPR transcriptional activator was recruited via MS2 hairpin. The repression of several genes was successfully achieved, with repression levels ranging from 3% to 32%, when the MXI1 transcriptional repressor was recruited via PP7 hairpin. Finally, CRISPR-STAR was applied to enhance fatty alcohol production by activating the FAR gene (encodes fatty acyl-CoA reductase) and repression of the PEX10 gene (encodes an integral membrane protein required for peroxisome biogenesis and matrix protein import). Compared to the non-targeting control, the bidirectionally regulated strain showed a 55.7% increase in yield to 778.8 mg/L. Our findings demonstrate that the CRISPR-STAR platform enables multi-mode regulation of genes, offering engineering opportunities to improve the productive performance of Y. lipolytica.
在多个方向上调控基因表达的能力对于最大化微生物细胞工厂的产量至关重要。然而,缺乏一种能够同时激活和抑制多个基因的调控工具限制了解脂耶氏酵母(一种生物生产的工业主力菌株)的操作多样性。为了解决这个问题,我们开发了一种CRISPR支架RNA(scRNAs)介导的转录激活和抑制(CRISPR-STAR)平台。首先,我们评估了在解脂耶氏酵母的内源和合成启动子上使用CRISPR进行双向调控的不同方法,并选择利用正交scRNAs来招募激活和抑制结构域。其次,通过引入替代的dCas蛋白、scRNA结构和激活剂对CRISPR-STAR进行了优化。当通过MS2发夹招募VPR转录激活剂时,合成启动子和内源启动子分别实现了2.6倍和54.9倍的激活。当通过PP7发夹招募MXI1转录抑制子时,成功实现了对几个基因的抑制,抑制水平在3%至32%之间。最后,将CRISPR-STAR应用于通过激活FAR基因(编码脂肪酰辅酶A还原酶)和抑制PEX10基因(编码过氧化物酶体生物发生和基质蛋白导入所需的整合膜蛋白)来提高脂肪醇的产量。与非靶向对照相比,双向调控的菌株产量提高了55.7%,达到778.8 mg/L。我们的研究结果表明,CRISPR-STAR平台能够实现基因的多模式调控,为改善解脂耶氏酵母的生产性能提供了工程学机会。